Price (delayed)
$47.66
Market cap
$574.77M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.51
Enterprise value
$494.96M
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
There are no recent dividends present for QTTB.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.